Signet Ring Adenocarcinoma of the Rectum
📧 Sign up to get email alerts when something new happens for Signet Ring Adenocarcinoma of the Rectum.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer [Phase 2]
A Phase 2 trial evaluating aflibercept in combination with FOLFOX6 for previously untreated Stage IV colorectal cancer has completed enrollm…
-
CLINICAL_TRIALS trial_result · 2025-02-05Clinical Trial Update: Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab [Phase 2]
A Phase 2 trial evaluated panitumumab with chemotherapy in patients with advanced colorectal cancer after bevacizumab treatment; the study i…
-
CLINICAL_TRIALS withdrawal · 2015-05-06Clinical Trial Update: Ziv-Aflibercept Followed by Ziv-Aflibercept, Fluorouracil, and Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer [Phase 2]
A Phase 2 clinical trial evaluating Ziv-Aflibercept with fluorouracil and leucovorin for Stage IV colorectal cancer has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-01-17Clinical Trial Update: Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer [EARLY_Phase 1]
An early-phase 1 trial evaluating cholecalciferol (25-[OH]-Vitamin D) for colorectal cancer was withdrawn and did not proceed.
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal Cancer [Phase 1]
Phase I study evaluating the safety, pharmacology, and biology of erlotinib (OSI-774) in combination with FOLFOX-4 and bevacizumab in advanc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.